David Kirn 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

FDMT Quotes by TradingView

David Kirn is Chief Executive Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 1.06 Million shares of FDMT, which is worth approximately $4.85 Million. The most recent transaction as insider was on Jul 10, 2024, when has been sold 12,923 shares (Common Stock) at a price of $22.49 per share, resulting in proceeds of $290,638. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.06M
0% 3M change
8.45% 12M change
Total Value Held $4.85 Million

David Kirn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2024
SELL
Open market or private sale
$290,638 $22.49 p/Share
12,923 Reduced 1.21%
1,059,153 Common Stock
Jul 10 2024
BUY
Exercise of conversion of derivative security
$195,137 $15.1 p/Share
12,923 Added 1.19%
1,072,076 Common Stock
Jun 24 2024
SELL
Open market or private sale
$298,683 $23.1 p/Share
12,930 Reduced 1.21%
1,059,153 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
$186,450 $14.42 p/Share
12,930 Added 1.19%
1,072,083 Common Stock
Feb 08 2024
SELL
Open market or private sale
$2,495,987 $27.13 p/Share
92,001 Reduced 7.99%
1,059,153 Common Stock
Jan 23 2024
SELL
Open market or private sale
$104,863 $18.41 p/Share
5,696 Reduced 0.49%
1,151,154 Common Stock
Jan 05 2024
SELL
Open market or private sale
$560,222 $19.84 p/Share
28,237 Reduced 2.38%
1,156,850 Common Stock
Jan 04 2024
SELL
Open market or private sale
$827,266 $20.31 p/Share
40,732 Reduced 3.32%
1,185,087 Common Stock
Dec 18 2023
SELL
Open market or private sale
$85,247 $18.13 p/Share
4,702 Reduced 0.38%
1,225,819 Common Stock
Dec 15 2023
SELL
Open market or private sale
$494,474 $17.27 p/Share
28,632 Reduced 2.27%
1,230,521 Common Stock
May 02 2023
SELL
Bona fide gift
-
600,000 Reduced 32.27%
1,259,153 Common Stock
Feb 22 2023
SELL
Open market or private sale
$332,598 $20.22 p/Share
16,449 Reduced 0.88%
1,859,153 Common Stock
Feb 21 2023
SELL
Open market or private sale
$381,716 $21.21 p/Share
17,997 Reduced 0.95%
1,875,602 Common Stock
Jan 20 2023
SELL
Open market or private sale
$174,138 $20.19 p/Share
8,625 Reduced 0.45%
1,893,599 Common Stock
Jan 19 2023
SELL
Open market or private sale
$218,306 $20.03 p/Share
10,899 Reduced 0.57%
1,902,224 Common Stock
Dec 16 2022
SELL
Open market or private sale
$1,242,330 $23.03 p/Share
53,944 Reduced 2.74%
1,913,123 Common Stock
Dec 15 2022
SELL
Open market or private sale
$785,122 $23.84 p/Share
32,933 Reduced 1.65%
1,967,067 Common Stock
DK

David Kirn

Chief Executive Officer
Emeryville, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FDMT